[Improved therapy of tuberculosis with a well tolerated INH derivative (INHG)].
D003523:Cycloserine / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use; D005965:Glucuronates / Q000627:therapeutic use*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D008875:Middle Aged; D011718:Pyrazinamide / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D005965:Glucuronates; D011718:Pyrazinamide; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin
Verbesserte Tuberkulosetherapie durch ein verträglicheres INH-Derivate (INHG)